RxDoctor Payments Data

Laura Poole

Nurse Practitioner · North Chesterfield, VANPI 1952855272

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Atricure, Inc. accounts for 77.6% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2022 at $15,208 and has fallen 92.7% since, to $1,107 in 2025. Among nurse practitioner clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,982in general payments, 2019–2025

Across 215 payments — averaging $92.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$16K
  • Boston Scientific$1K
  • Medtronic$645
  • Novartis$298
  • Pfizer$254
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$218
  • plus $2K from 22 others

What the payments were for

  • Consulting fees$10,60053%
  • Travel & lodging$3,58018%
  • Food & beverage$5,77229%
  • Entertainment$310%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,982 in reported general payments places this provider in the 95th percentile of 2,166 nurse practitioner providers in Virginia.

See all nurse practitioner providers in Virginia

Medicare billing

Part B allowed, 2024
$16,531
Medicare patients
131
Services billed
254

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban120$109,613
XareltoRivaroxaban23$27,798
Flecainide Acetate39$1,409
Propafenone Hcl ErPropafenone Hcl14$1,308
Diltiazem 24hr Er (Cd)Diltiazem Hcl45$1,265
Metoprolol Succinate94$1,125
Amiodarone Hcl69$654
Losartan Potassium22$190
Metoprolol Tartrate51$168
Lisinopril19$108
Carvedilol18$94
Amlodipine Besylate29$91
Furosemide15$27
Hydrochlorothiazide14$25

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$254$109,613120 claims
Johnson & JohnsonXarelto$145$27,79823 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,166 nurse practitioner providers in Virginia.

Other nurse practitioner in North Chesterfield

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →